tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yigal Nochomovitz, 84 are a HOLD (17.95%), 365 are a BUY (77.99%), 19 are a SELL (4.06%).
Analyst Yigal Nochomovitz, currently employed at CITI, carries an average stock price target met ratio of 48.09% that have a potential upside of 56.22% achieved within 168 days.
Yigal Nochomovitzās has documented 919 price targets and ratings displayed on 49 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRBU, Caribou Biosciences at 26-Nov-2024.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 12/24/2015. The price target of $19 was fulfilled within 4 days with a profit of $16.57 (46.58%) receiving and performance score of 116.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$13
2 years 3 months 25 days ago
(29-Aug-2022)
1/5 (20%)
$4.7 (56.63%)
176
Hold
2 years 4 months ago
(24-Aug-2022)
0/1 (0%)
$6.53 (25.64%)
Hold
$20
2 years 4 months ago
(24-Aug-2022)
0/4 (0%)
$14.21 (245.42%)
Buy
$15.25
$27
2 years 4 months 1 days ago
(23-Aug-2022)
7/11 (63.64%)
$0.09 (0.59%)
149
Hold
$15.25
$30
2 years 4 months 1 days ago
(23-Aug-2022)
1/3 (33.33%)
$0.09 (0.59%)
48
Which stock is Yigal Nochomovitz is most bullish on?
Which stock is Yigal Nochomovitz is most reserved on?
What Year was the first public recommendation made by Yigal Nochomovitz?
